Chronic humoral rejection of human kidney allografts is associated with mmp-2 accumulation in podocytes and its release in the urine

American Journal of Transplantation

Volumn 10, Issue 11, 2010, Pages 2463-2471

  Wong, W ^a   DeVito, J ^a   Nguyen, H ^a   Sarracino, D ^b   Porcheray, F ^a   Dargon, I ^a   Pelle, P D ^a   Collins, A B ^a   Tolkoff Rubin, N ^a   Smith, R N ^a   Colvin, R ^a   Zorn, E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LABORATORY FOR MOLECULAR MEDICINE   (United States)

Author keywords

Chronic humoral rejection; kidney transplantation; MMP 2

Indexed keywords

GELATINASE A;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYMATIC ASSAY; FEMALE; GLOMERULAR DYSFUNCTION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; URINARY EXCRETION;

FEMALE; FIBROSIS; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PODOCYTES; PROTEINURIA;

EID: 78349246789     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03290.x     Document Type: Article

References (20)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B,. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378 -383.
2. Sis B, Mengel M, Hass M, et al,. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464 -474.
3. Colvin RB,. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046 -1056.
4. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al,. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804 -2812.
5. Terasaki PI, Ozawa M,. Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial. Transplantation 2005; 80: 1194 -1197.
6. Terasaki PI, Ozawa M, Castro R,. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007; 7: 408 -415.
7. Racusen LC, Solez K, Colvin RB, et al,. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713 -723.
8. Baricos WH, Cortez SL, El-Dahr SS, Schnaper HW,. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 1995; 47: 1039 -1047.
9. Lovett DH, Johnson RJ, Marti HP, Martin J, Davies M, Couser WG,. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 1992; 141: 85 -98.
10. Rodrigo E, Lopez-Hoyos M, Escallada R, et al,. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrol Dial Transplant 2000; 15: 2041 -2045.
11. Hayashi K, Horikoshi S, Osada S, Shofuda K, Shirato I, Tomino Y,. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis. J Pathol 2000; 191: 299 -305.
12. Racusen LC, Colvin RB, Solez K, et al,. Antibody-mediated rejection criteria -an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708 -714.
13. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH,. Matrix metalloproteinase 2 and basement membrane integrity: A unifying mechanism for progressive renal injury. FASEB J 2006; 20: 1898 -1900.
14. Endo T, Nakabayashi K, Sekiuchi M, Kuroda T, Soejima A, Yamada A,. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: Study based on an enzyme-linked assay and immunohistochemical staining. Clin Exp Nephrol 2006; 10: 253 -261.
15. Sanders JS, Huitema MG, Hanemaaijer R, Van Goor H, Kallenberg CG, Stegeman CA,. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Renal Physiol 2007; 293: F1927 -F1934.
16. Bai Y, Wang L, Li Y, et al,. High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes. Cell Physiol Biochem 2006; 17: 57 -68.
17. Serluca FC, Drummond IA, Fishman MC,. Endothelial signaling in kidney morphogenesis: A role for hemodynamic forces. Curr Biol 2002; 12: 492 -497.
18. Fahim T, Bohmig GA, Exner M, et al,. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7: 385 -393.
19. Sanders JS, Van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA,. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2004; 19: 1412 -1419.
20. Porcheray F, Devito J, Yeap BY, et al,. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 2010; 89: 1239 -1246.